Preoperative intralesional injection of triamcinolone acetonide for a large head and neck lymphangioma in a baby: a case report

Main Article Content

Julius July
Sophie Peeters

Abstract

Lymphangiomas (LMs) are uncommon congenital malformations of the lymphatic system, with an estimated incidence of one in 2,000 to 4,000 live births.1 About half of these lesions are diagnosed at birth, and by two years of age, 90% of those with lesions have been diagnosed.2 Histologically, LMs are benign lesions; however, they can pose a serious threat to the patient due to possible growth into surrounding structures, sometimes causing life-threatening complications. Treatment of large head and neck lymphangiomas in young infants is very challenging, due to the risk of surgical complications. Further challenges include the limited volume of blood loss that infants can tolerate, the lack of the option for radiotherapy or radiosurgery, and the high chance of life-threatening complications if the LM is not treated. Here, we report a case of a two-month-old baby girl presenting with a large head and neck lymphangioma. She was successfully treated with intralesional triamcinolone acetonide injections, followed by surgical resection of the lesion.

Article Details

How to Cite
1.
July J, Peeters S. Preoperative intralesional injection of triamcinolone acetonide for a large head and neck lymphangioma in a baby: a case report. PI [Internet]. 5Jan.2018 [cited 17Sep.2019];57(5):274-. Available from: https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/1340
Section
Articles
Author Biography

Julius July, Department of Neurosurgery, Pelita Harapan University Medical School/Neuroscience Centre Siloam Hospital Lippo Village, Tangerang

Staff of Neurosurgeon, Director of Clinical Education
Received 2017-04-04
Accepted 2017-10-30
Published 2018-01-05

References

1. Bagrodia N, Defnet AM, Kandel JJ. Management of lymphatic malformations in children. Curr Opin Pediatr. 2015;27:356–63.
2. Khurana S, Vij A, Singal A, Pandhi D. Lymphangioma of the tongue: response to intralesional steroids. J Dermatolog Treat. 2006;17:124–6.
3. Farnoosh S, Don D, Koempel J, Panossian A, Anselmo D, Stanley P. Efficacy of doxycycline and sodium tetradecyl sulfate sclerotherapy in pediatric head and neck lymphatic malformations. Int J Pediatr Otorhinolaryngol. 2015;79:883–7.
4. Alvi A, Myssiorek D, Reppucci A. Unusual presentations of lymphangioma. Arch Otolaryngol Head Neck Surg. 1993;119:1358–61.
5. Grasso DL, Pelizzo G, Zocconi E, Schleef J. Lymphangiomas of the head and neck in children. Acta Otorhinolaryngol Ital. 2008;28:17–20.
6. Okazaki T, Iwatani S, Yanai T, Kobayashi H, Kato Y, Marusasa T, et al. Treatment of lymphangioma in children: our experience of 128 cases. J Pediatr Surg. 2007;42:386–9.
7. Tawfik HA, Budin H, Dutton JJ. Lack of response to systemic corticosteroids in patients with lymphangioma. Ophthal Plast Reconstr Surg. 2005;21:302–5.
8. Sires BS, Goins CR, Anderson RL, Holds JB. Systemic corticosteroid use in orbital lymphangioma. Ophthal Plast Reconstr Surg. 2001;17:85–90.